2006

1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

   Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326